Eight Companies Initiate Voluntary Recall of Enalapril Generics Due to Deviations from Specifications

Eight generic drug makers, which manufacture and market generic versions of the antihypertensive agent Renivace (enalapril maleate) have begun voluntarily recalling their products due to non-conformity with approved specifications and have stopped supplies. Resumption of supplies is expected to take...read more